• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂溶性维生素在异基因干细胞移植患者清髓预处理后移植物抗宿主病中的作用。

The role of fat-soluble vitamins for graft-versus host disease after myeloablative conditioning in allogeneic stem cell transplanted patients.

作者信息

Skaarud Kristin J, Gudmundstuen Anne Marte, Pesonen Maiju, Hjermstad Marianne J, Iversen Per Ole, Tjønnfjord Geir E

机构信息

Department of Haematology, Oslo University Hospital, P.O. Box 4950, Oslo, 0424, Norway.

Lovisenberg Diaconal University College, Oslo, Norway.

出版信息

Sci Rep. 2025 Jan 11;15(1):1675. doi: 10.1038/s41598-024-84805-2.

DOI:10.1038/s41598-024-84805-2
PMID:39799129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11724905/
Abstract

Whether the fat-soluble vitamins A, D, E, and K are associated with development of graft-versus-host disease (GvHD) after allogeneic stem cell transplantation, is unclear. We assessed if the levels of these vitamins were associated with development of GvHD during the first year after transplantation using data from a two-armed randomized nutritional intervention trial. Changes in plasma levels during 1-year follow-up were analyzed using a linear mixed model for repeated measurements. Vitamin A, D, E, and K levels changed significantly the first year in both study arms (p < 0.001). Higher levels of vitamin E over time were associated with less acute GvHD grades 3-4 (OR = 0.997, 95% CI: (0.994, 0.999), p = 0.017). No associations were found with vitamin A, D, E and K levels and chronic GvHD. Multivariable analysis adjusted for treatment group, age, pre-transplant vitamin level and risk factors for GvHD did not change the results. Six weeks post-transplantation, higher levels of vitamin E were associated with less acute GvHD grades 3-4, (p = 0.012). In conclusion, we found an association between higher levels of vitamin E over time and less severe acute GvHD. Whether this reflects a causal relationship warrants further study. ClinicalTrials.gov (NCT01181076).

摘要

脂溶性维生素A、D、E和K是否与异基因干细胞移植后移植物抗宿主病(GvHD)的发生有关尚不清楚。我们使用双臂随机营养干预试验的数据评估了这些维生素的水平是否与移植后第一年GvHD的发生有关。使用线性混合模型对重复测量数据进行分析,以评估1年随访期间血浆水平的变化。在两个研究组中,维生素A、D、E和K的水平在第一年都有显著变化(p<0.001)。随着时间推移,较高的维生素E水平与较轻的3-4级急性GvHD相关(OR=0.997,95%CI:(0.994,0.999),p=0.017)。未发现维生素A、D、E和K水平与慢性GvHD有关。对治疗组、年龄、移植前维生素水平和GvHD危险因素进行多变量分析后,结果未改变。移植后6周,较高的维生素E水平与较轻的3-4级急性GvHD相关(p=0.012)。总之,我们发现随着时间推移较高的维生素E水平与较轻的急性GvHD之间存在关联。这是否反映因果关系值得进一步研究。ClinicalTrials.gov(NCT01181076)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aab8/11724905/5d31b7d7d624/41598_2024_84805_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aab8/11724905/3c2ccba752f4/41598_2024_84805_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aab8/11724905/5d31b7d7d624/41598_2024_84805_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aab8/11724905/3c2ccba752f4/41598_2024_84805_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aab8/11724905/5d31b7d7d624/41598_2024_84805_Fig2_HTML.jpg

相似文献

1
The role of fat-soluble vitamins for graft-versus host disease after myeloablative conditioning in allogeneic stem cell transplanted patients.脂溶性维生素在异基因干细胞移植患者清髓预处理后移植物抗宿主病中的作用。
Sci Rep. 2025 Jan 11;15(1):1675. doi: 10.1038/s41598-024-84805-2.
2
Pre-transplantation vitamin E levels and acute graft-versus-host disease after non-myeloablative allogeneic hematopoietic cell transplantation.移植前维生素 E 水平与非清髓性异基因造血细胞移植后急性移植物抗宿主病。
Transpl Immunol. 2022 Oct;74:101650. doi: 10.1016/j.trim.2022.101650. Epub 2022 Jun 16.
3
Vitamin E and acute graft-versus-host disease after myeloablative allogeneic hematopoietic cell transplantation.维生素 E 与骨髓清除性异基因造血细胞移植后急性移植物抗宿主病。
Eur J Haematol. 2021 Mar;106(3):417-424. doi: 10.1111/ejh.13567. Epub 2020 Dec 19.
4
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。
Dan Med Bull. 2007 May;54(2):112-39.
5
Plasma Nucleosome Levels and Risk of Acute Graft-Versus-Host Disease After Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Cohort Study.清髓性异基因造血干细胞移植后血浆核小体水平与急性移植物抗宿主病风险:一项单中心队列研究
Transplant Cell Ther. 2025 May;31(5):301.e1-301.e10. doi: 10.1016/j.jtct.2025.02.015. Epub 2025 Feb 18.
6
Pre-transplantation plasma vitamin D levels and acute graft-versus-host disease after myeloablative hematopoietic cell transplantation in adults.成人清髓性造血细胞移植前血浆维生素D水平与急性移植物抗宿主病
Transpl Immunol. 2021 Oct;68:101437. doi: 10.1016/j.trim.2021.101437. Epub 2021 Jul 15.
7
Predictive Values of Early Suppression of Tumorigenicity 2 for Acute GVHD and Transplant-related Complications after Allogeneic Stem Cell Transplantation: Prospective Observational Study.肿瘤致瘤性2早期抑制对异基因干细胞移植后急性移植物抗宿主病及移植相关并发症的预测价值:前瞻性观察研究
Turk J Haematol. 2020 Feb 20;37(1):20-29. doi: 10.4274/tjh.galenos.2019.2019.0139. Epub 2019 Aug 29.
8
Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplant.在亲缘和非亲缘供者异基因造血细胞移植中,采用西罗莫司、他克莫司和低剂量甲氨蝶呤预防非清髓或减低强度预处理后的移植物抗宿主病。
Leuk Lymphoma. 2015 Mar;56(3):663-70. doi: 10.3109/10428194.2014.930851. Epub 2014 Aug 6.
9
Impact of Underlying Disease and Total Body Irradiation on the Incidence of Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation.基础疾病和全身照射对异基因造血细胞移植后移植物抗宿主病发生率的影响。
Transplant Cell Ther. 2025 Mar;31(3):176.e1-176.e8. doi: 10.1016/j.jtct.2024.12.024. Epub 2025 Jan 5.
10
Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation.体外光分离术预防标准清髓性预处理和异基因造血干细胞移植患者发生急性移植物抗宿主病。
Bone Marrow Transplant. 2010 Jun;45(6):1068-76. doi: 10.1038/bmt.2009.307. Epub 2009 Nov 16.

本文引用的文献

1
A randomized phase 2 trial of oral vitamin A for graft-versus-host disease in children and young adults.一项口服维生素 A 治疗儿童和青年成人移植物抗宿主病的随机 2 期临床试验。
Blood. 2024 Mar 21;143(12):1181-1192. doi: 10.1182/blood.2023022865.
2
Chronic graft-versus-host disease in pediatric patients: Differences and challenges.儿童慢性移植物抗宿主病:差异与挑战。
Blood Rev. 2023 Jul;60:101054. doi: 10.1016/j.blre.2023.101054. Epub 2023 Feb 8.
3
Pre-transplantation vitamin E levels and acute graft-versus-host disease after non-myeloablative allogeneic hematopoietic cell transplantation.
移植前维生素 E 水平与非清髓性异基因造血细胞移植后急性移植物抗宿主病。
Transpl Immunol. 2022 Oct;74:101650. doi: 10.1016/j.trim.2022.101650. Epub 2022 Jun 16.
4
Novel Insights Into the Mechanism of GVHD-Induced Tissue Damage.GVHD 导致组织损伤机制的新见解。
Front Immunol. 2021 Aug 27;12:713631. doi: 10.3389/fimmu.2021.713631. eCollection 2021.
5
Pre-transplantation plasma vitamin D levels and acute graft-versus-host disease after myeloablative hematopoietic cell transplantation in adults.成人清髓性造血细胞移植前血浆维生素D水平与急性移植物抗宿主病
Transpl Immunol. 2021 Oct;68:101437. doi: 10.1016/j.trim.2021.101437. Epub 2021 Jul 15.
6
Vitamin E and acute graft-versus-host disease after myeloablative allogeneic hematopoietic cell transplantation.维生素 E 与骨髓清除性异基因造血细胞移植后急性移植物抗宿主病。
Eur J Haematol. 2021 Mar;106(3):417-424. doi: 10.1111/ejh.13567. Epub 2020 Dec 19.
7
The effect of vitamin E supplementation on selected inflammatory biomarkers in adults: a systematic review and meta-analysis of randomized clinical trials.维生素 E 补充剂对成年人选定炎症生物标志物的影响:随机临床试验的系统评价和荟萃分析。
Sci Rep. 2020 Oct 14;10(1):17234. doi: 10.1038/s41598-020-73741-6.
8
Pretransplantation vitamin A plasma levels and risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植前血浆维生素A水平与急性移植物抗宿主病风险
Bone Marrow Transplant. 2020 Jul;55(7):1457-1459. doi: 10.1038/s41409-019-0760-5. Epub 2019 Nov 26.
9
Body weight, body composition and survival after 1 year: follow-up of a nutritional intervention trial in allo-HSCT recipients.体重、身体成分与 1 年后的生存:异基因造血干细胞移植受者营养干预试验的随访。
Bone Marrow Transplant. 2019 Dec;54(12):2102-2109. doi: 10.1038/s41409-019-0638-6. Epub 2019 Aug 27.
10
The Role of Micronutrients in Graft-VS.-Host Disease: Immunomodulatory Effects of Vitamins A and D.微量元素在移植物抗宿主病中的作用:维生素 A 和 D 的免疫调节作用。
Front Immunol. 2018 Dec 6;9:2853. doi: 10.3389/fimmu.2018.02853. eCollection 2018.